Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR35 | Q9HC97 | 8/20 | 1.00 |
| ▸ | USP2 | O75604 | 1/20 | 1.00 |
| ▸ | POLB | P06746 | 1/20 | 1.00 |
| ▸ | HPGD | P15428 | 1/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 1/20 | 1.00 |
| ▸ | ALOX12 | P18054 | 1/20 | 1.00 |
| ▸ | CASP1 | P29466 | 1/20 | 1.00 |
| ▸ | CASP7 | P55210 | 1/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 1.00 |
| ▸ | F12 | P00748 | 3/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.62 |
| ▸ | MAPT | P10636 | 1/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
| ▸ | MAOB | P27338 | 2/20 | 0.54 |
| ▸ | MAOA | P21397 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1367802 | 0.88 | GPR35 (0.79) | GPR35USP2POLBHPGDALOX15 | |
| SCHEMBL30110303 | 0.87 | GPR35 (0.77) | GPR35USP2POLBHPGDALOX15 | |
| SCHEMBL30110275 | 0.85 | GPR35 (0.74) | GPR35USP2POLBHPGDALOX15 | |
| SCHEMBL17037290 | 0.85 | GPR35 (0.74) | GPR35USP2POLBHPGDALOX15 | |
| SCHEMBL52311 | 0.82 | HPGD (0.69) | GPR35USP2POLBHPGDALOX15 | |
| SCHEMBL18306420 | 0.79 | MAOA (0.71) | GPR35USP2POLBHPGDALOX15 | |
| SCHEMBL11494991 | 0.78 | MAOB (0.77) | GPR35USP2POLBHPGDALOX15 | |
| SCHEMBL22041606 | 0.78 | GPR35 (0.71) | GPR35USP2POLBHPGDALOX15 | |
| SCHEMBL2896018 | 0.77 | GPR35 (0.63) | GPR35USP2POLBHPGDALOX15 | |
| Hydrochloric Acid SCHEMBL11746382 | 0.76 | GPR35 (0.61) | GPR35USP2POLBHPGDALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2902388-B1 | CONDENSATION PRODUCT OF THEANINE DERIVATIVE AND CARBOXYLIC ACID COUMARIN DERIVATIVE, INTERMEDIATE OF THE CONDENSATION PRODUCT, METHOD FOR PREPARING SAME, AND USE THEREOF | SHANDONG YINGDONG YINGHAO BIOTECHNOLOGY INC (CN) | 2019-03-13 | — | — | EP | disclosed |
| EP-2902388-B1 | CONDENSATION PRODUCT OF THEANINE DERIVATIVE AND CARBOXYLIC ACID COUMARIN DERIVATIVE, INTERMEDIATE OF THE CONDENSATION PRODUCT, METHOD FOR PREPARING SAME, AND USE THEREOF | SHANDONG YINGDONG YINGHAO BIOTECHNOLOGY INC (CN) | 2019-03-13 | — | — | EP | disclosed |
| US-9518038-B2 | Condensation product of theanine derivative and carboxylic acid coumarin derivative, its intermediate, preparation method and use thereof | SHANDONG YINGDONG YINGHAO BIOTECHNOLOGY, INC. (CN) | 2016-12-13 | — | — | US | disclosed |
| US-9518038-B2 | Condensation product of theanine derivative and carboxylic acid coumarin derivative, its intermediate, preparation method and use thereof | SHANDONG YINGDONG YINGHAO BIOTECHNOLOGY, INC. (CN) | 2016-12-13 | — | — | US | disclosed |
| US-20150239861-A1 | CONDENSATION PRODUCT OF THEANINE DERIVATIVE AND CARBOXYLIC ACID COUMARIN DERIVATIVE, ITS INTERMEDIATE, PREPARATION METHOD AND USE THEREOF | ZHANG, GUOYING (CN) | 2015-08-27 | — | — | US | disclosed |
| US-20150239861-A1 | CONDENSATION PRODUCT OF THEANINE DERIVATIVE AND CARBOXYLIC ACID COUMARIN DERIVATIVE, ITS INTERMEDIATE, PREPARATION METHOD AND USE THEREOF | ZHANG, GUOYING (CN) | 2015-08-27 | — | — | US | disclosed |
| EP-2902388-A1 | CONDENSATION PRODUCT OF THEANINE DERIVATIVE AND CARBOXYLIC ACID COUMARIN DERIVATIVE, INTERMEDIATE OF THE CONDENSATION PRODUCT, METHOD FOR PREPARING SAME, AND USE THEREOF | Yantai University (CN) | 2015-08-05 | — | — | EP | disclosed |
| CN-104144919-A | CONDENSATION PRODUCT OF THEANINE DERIVATIVE AND CARBOXYLIC ACID COUMARIN DERIVATIVE, INTERMEDIATE OF THE CONDENSATION PRODUCT, METHOD FOR PREPARING SAME, AND USE THEREOF | WUWEI COUNTY MARINE BIOTECHNOLOGY CO LTD | 2014-11-12 | — | — | CN | disclosed |
| US-5482986-A | ULTRAVIOLET RADIATION ABSORBER FOR THERMOPLASTIC RESINS; COLORLESS, HEAT RESISTANCE | MITSUI TOATSU CHEMICALS, INC. (JP) | 1996-01-09 | — | — | US | disclosed |
| EP-0635504-A1 | Benzopyran compound and use of the same | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1995-01-25 | — | — | EP | disclosed |
| US-4343938-A | 7-[Dα-(Coumarin-3-carboxamido)arylacetamido]-cephalosporanic acids or salts | AMERICAN CYANAMID COMPANY (US) | 1982-08-10 | — | — | US | disclosed |
| US-4320133-A | Penicillins and their antibacterial use | SANDOZ LTD. (CH) | 1982-03-16 | — | — | US | disclosed |
| US-4317774-A | 6-[D-α-(Coumarin-3-carboxamido)arylacetamido]-penicillanic acids or salts | AMERICAN CYANAMID COMPANY (US) | 1982-03-02 | — | — | US | disclosed |
| EP-0003115-A1 | Penicillins, per se and for use as antibacterially active antibiotics and their production | SANDOZ AG (CH) | 1979-07-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150239861-A1 | CONDENSATION PRODUCT OF THEANINE DERIVATIVE AND CARBOXYLIC ACID COUMARIN DERIVATIVE, ITS INTERMEDIATE, PREPARATION METHOD AND USE THEREOF | OGDH, C9, IRAK3 | GPR35 3949/4885USP2 1903/4885POLB 1599/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.